199 related articles for article (PubMed ID: 26290438)
21. The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer.
Sakimura S; Sugimachi K; Kurashige J; Ueda M; Hirata H; Nambara S; Komatsu H; Saito T; Takano Y; Uchi R; Sakimura E; Shinden Y; Iguchi T; Eguchi H; Oba Y; Hoka S; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1436-43. PubMed ID: 25707493
[TBL] [Abstract][Full Text] [Related]
22. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
23. MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells.
Zhang L; Wang X; Chen P
BMC Cancer; 2013 Jun; 13():290. PubMed ID: 23768087
[TBL] [Abstract][Full Text] [Related]
24. miR-449a targets Flot2 and inhibits gastric cancer invasion by inhibiting TGF-β-mediated EMT.
Li Q; Peng J; Li X; Leng A; Liu T
Diagn Pathol; 2015 Nov; 10():202. PubMed ID: 26576674
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of microRNA-224 -inhibites growth and epithelial-to-mesenchymal transition phenotype -via modulating SUFU expression in bladder cancer cells.
Miao X; Gao H; Liu S; Chen M; Xu W; Ling X; Deng X; Rao C
Int J Biol Macromol; 2018 Jan; 106():234-240. PubMed ID: 28780419
[TBL] [Abstract][Full Text] [Related]
26. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
Lei Y; Li B; Tong S; Qi L; Hu X; Cui Y; Li Z; He W; Zu X; Wang Z; Chen M
PLoS One; 2015; 10(2):e0117809. PubMed ID: 25658842
[TBL] [Abstract][Full Text] [Related]
27. Circular RNA circMTO1 suppresses bladder cancer metastasis by sponging miR-221 and inhibiting epithelial-to-mesenchymal transition.
Li Y; Wan B; Liu L; Zhou L; Zeng Q
Biochem Biophys Res Commun; 2019 Jan; 508(4):991-996. PubMed ID: 30551873
[TBL] [Abstract][Full Text] [Related]
28. Down-regualtion of miR-106b induces epithelial-mesenchymal transition but suppresses metastatic colonization by targeting Prrx1 in colorectal cancer.
Zheng L; Zhang Y; Lin S; Sun A; Chen R; Ding Y; Ding Y
Int J Clin Exp Pathol; 2015; 8(9):10534-44. PubMed ID: 26617763
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-338-3p inhibits the progression of bladder cancer through regulating ETS1 expression.
Zhang L; Yan R; Zhang SN; Zhang HZ; Ruan XJ; Cao Z; Gu XZ
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1986-1995. PubMed ID: 30915741
[TBL] [Abstract][Full Text] [Related]
30. Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells.
Tan J; Qiu K; Li M; Liang Y
FEBS Lett; 2015 Oct; 589(20 Pt B):3175-81. PubMed ID: 26318860
[TBL] [Abstract][Full Text] [Related]
31. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
[TBL] [Abstract][Full Text] [Related]
32. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression.
Bo J; Yang G; Huo K; Jiang H; Zhang L; Liu D; Huang Y
FEBS J; 2011 Mar; 278(5):786-92. PubMed ID: 21205209
[TBL] [Abstract][Full Text] [Related]
33. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
[TBL] [Abstract][Full Text] [Related]
34. miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion.
Huang J; Wang B; Hui K; Zeng J; Fan J; Wang X; Hsieh JT; He D; Wu K
Oncol Rep; 2016 Sep; 36(3):1693-701. PubMed ID: 27430302
[TBL] [Abstract][Full Text] [Related]
35. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
36. HMGN5 promotes IL-6-induced epithelial-mesenchymal transition of bladder cancer by interacting with Hsp27.
Yao K; He L; Gan Y; Liu J; Tang J; Long Z; Tan J
Aging (Albany NY); 2020 Apr; 12(8):7282-7298. PubMed ID: 32315283
[TBL] [Abstract][Full Text] [Related]
37. MiR-203a functions as a tumor suppressor in bladder cancer by targeting SIX4.
Na XY; Shang XS; Zhao Y; Ren PP; Hu XQ
Neoplasma; 2019 Mar; 66(2):211-221. PubMed ID: 30509104
[TBL] [Abstract][Full Text] [Related]
38. MiR-125a-5p suppresses bladder cancer progression through targeting FUT4.
Zhang Y; Zhang D; Lv J; Wang S; Zhang Q
Biomed Pharmacother; 2018 Dec; 108():1039-1047. PubMed ID: 30372804
[TBL] [Abstract][Full Text] [Related]
39. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
[TBL] [Abstract][Full Text] [Related]
40. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
